TradingView
TheCryptoChartWhisperer
2022年3月10日晚上10點05分

IFRX 1D Continued 看多

InflaRx N.V.NASDAQ

描述

test
Just having some fun after a great ski trip to Breckenridge, Co for a couple of weeks. Let's get back into it.

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

交易結束:目標達成

更多